mci 154 has been researched along with dpi 201-106 in 1 studies
Studies (mci 154) | Trials (mci 154) | Recent Studies (post-2010) (mci 154) | Studies (dpi 201-106) | Trials (dpi 201-106) | Recent Studies (post-2010) (dpi 201-106) |
---|---|---|---|---|---|
65 | 1 | 0 | 104 | 4 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Tombe, P; Doye, A; Gwathmey, JK; Ito, T; Li, X; Liao, R; Okafor, C; Perreault-Micale, C; Stepanek, A | 1 |
1 other study(ies) available for mci 154 and dpi 201-106
Article | Year |
---|---|
Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine.
Topics: Ca(2+) Mg(2+)-ATPase; Caffeine; Calcium; Cardiomyopathies; Cardiotonic Agents; Heart; Heart Ventricles; Humans; Myocardium; Myofibrils; Myosins; Piperazines; Pyridazines | 2003 |